About the Journal

Journal of Cancer Research and Therapeutic Oncology is an international, peer-reviewed, open access journal committed to publishing high-quality original research, reviews, clinical studies, and scholarly contributions in the broad fields of cancer research, oncology, and therapeutic sciences. The journal provides a multidisciplinary platform for oncologists, cancer researchers, clinicians, biomedical scientists, healthcare professionals, and other experts to share innovative discoveries, clinical developments, and emerging therapeutic approaches that advance the prevention, diagnosis, management, and treatment of cancer.

In an era of rapidly evolving cancer biology, molecular oncology, precision medicine, and therapeutic technologies, the dissemination of reliable and impactful scientific knowledge has become more important than ever. The Journal of Cancer Research and Therapeutic Oncology is established with the vision of promoting excellence in cancer research and facilitating the global exchange of scientific knowledge that bridges the gap between fundamental discoveries, translational research, and clinical applications.

The journal emphasizes the publication of original and significant contributions that advance the understanding of cancer biology, molecular mechanisms, tumor development and progression, cancer genetics and genomics, biomarkers, disease pathogenesis, diagnostic methodologies, prevention strategies, and therapeutic interventions. By maintaining a strong commitment to scientific rigor and ethical publishing practices, the journal strives to ensure that all published research meets high standards of academic integrity, quality, and relevance.

As an international journal, Journal of Cancer Research and Therapeutic Oncology welcomes submissions from researchers, clinicians, healthcare professionals, and academic institutions worldwide. The journal aims to encourage collaboration among experts from diverse disciplines, fostering the exchange of knowledge and innovative ideas that can contribute to advances in cancer research and patient care.

The journal provides equal opportunities for researchers worldwide to disseminate their scientific findings, promoting inclusivity and diversity in cancer research and scientific communication. Through global participation and interdisciplinary collaboration, the journal seeks to support international efforts to address the complex challenges associated with cancer prevention, diagnosis, treatment, and management.

Peer Review Excellence

The journal follows a rigorous double-blind peer review process, ensuring that both authors and reviewers remain anonymous throughout the evaluation process. This approach eliminates bias and guarantees a fair, objective, and transparent review of all submitted manuscripts.

Each submission undergoes a thorough assessment by qualified experts in the relevant field, who evaluate the manuscript based on originality, scientific validity, methodological soundness, and relevance to the journal’s focus. The editorial board carefully considers reviewers’ feedback before making final decisions regarding acceptance, revision, or rejection.

To meet the needs of researchers requiring timely publication, the journal also offers a fast-track review process, enabling rapid evaluation and publication of high-priority manuscripts without compromising the quality of peer review. This feature is particularly beneficial for time-sensitive research findings and emerging scientific developments.

Open Access Policy and Creative Commons Licensing

Journal of Cancer Research and Therapeutic Oncology operates under a full open access publishing model, ensuring that all articles are freely accessible to readers worldwide without subscription barriers. This approach enhances the dissemination and impact of research, allowing knowledge to reach a broader audience including researchers, clinicians, policymakers, and the general public.

All published articles are distributed under Creative Commons licensing, which permits users to read, download, copy, distribute, and reproduce the content in any medium, provided that appropriate credit is given to the original authors. This policy supports the principles of transparency, accessibility, and knowledge sharing in scientific research.

Open access publishing not only increases the visibility of authors’ work but also contributes to higher citation rates and broader academic recognition.

Digital Identification and Indexing Support

To ensure the long-term accessibility and traceability of published research, the journal assigns a Digital Object Identifier (DOI) to each article through Crossref. This enables accurate citation, easy retrieval, and integration with global research databases.

In addition, all published articles are submitted for indexing in Google Scholar after publication, enhancing discoverability and ensuring that research is accessible to the global academic community. The journal continuously works toward inclusion in additional indexing and abstracting databases to further expand its reach and credibility

Language and Accessibility

The journal publishes all manuscripts in English, the universally accepted language of scientific communication. This ensures clarity, consistency, and accessibility for an international audience.

Authors are encouraged to present their research in a clear and concise manner, enabling readers from diverse academic and professional backgrounds to understand and apply the findings effectively. The journal also supports the use of standardized scientific terminology and formatting to maintain consistency across publications.

Ethical Standards and Integrity

The journal is committed to maintaining the highest standards of publication ethics and academic integrity. All submissions are expected to be original and free from plagiarism, data fabrication, or any form of unethical practice.

Authors are required to disclose any potential conflicts of interest and ensure that their research complies with ethical guidelines, particularly in studies involving human participants or animals. The journal follows internationally recognized ethical standards to safeguard the credibility and reliability of published research.

By enforcing strict ethical policies, the journal ensures trust among authors, reviewers, and readers.

Contribution to Scientific Advancement

The primary goal of the Journal of Cancer Research and Therapeutic Oncology is to contribute meaningfully to the advancement of cancer research, oncology, and therapeutic innovation. By publishing high-quality research and encouraging interdisciplinary collaboration, the journal aims to support scientific efforts to address the complex challenges associated with cancer.

The journal encourages innovative studies that contribute to improved understanding of cancer biology, early detection, diagnostic technologies, biomarkers, prevention strategies, personalized medicine, targeted therapies, immunotherapy, chemotherapy, radiotherapy, surgical oncology, supportive care, and emerging treatment approaches.

Through its commitment to scientific excellence, accessibility, collaboration, and research integrity, the Journal of Cancer Research and Therapeutic Oncology aspires to serve as a valuable source of knowledge for the international cancer research and oncology community.

By fostering innovation and promoting the widespread dissemination of cancer research findings, the journal contributes to global efforts to better understand cancer, improve prevention and early detection, develop more effective therapeutic strategies, and ultimately enhance patient care and human health worldwide.